HOWL
Werewolf Therapeutics Inc

1,054
Mkt Cap
$29.13M
Volume
429,986.00
52W High
$2.38
52W Low
$0.5301
PE Ratio
-0.37
HOWL Fundamentals
Price
$0.6002
Prev Close
$0.6319
Open
$0.63
50D MA
$0.6606
Beta
1.69
Avg. Volume
508,396.30
EPS (Annual)
-$1.63
P/B
0.96
Rev/Employee
$40,978.26
$9.00
Loading...
Loading...

About

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
46

Frequently Asked Questions

What is Market Cap of Werewolf Therapeutics Inc?
What is the 52-week high for Werewolf Therapeutics Inc?
What is the 52-week low for Werewolf Therapeutics Inc?
What is Werewolf Therapeutics Inc stock price today?
What was Werewolf Therapeutics Inc stock price yesterday?
What is the PE ratio of Werewolf Therapeutics Inc?
What is the Price-to-Book ratio of Werewolf Therapeutics Inc?
What is the 50-day moving average of Werewolf Therapeutics Inc?
How many employees does Werewolf Therapeutics Inc have?

Latest HOWL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.